Quantcast

Latest Amides Stories

2014-04-07 08:31:34

Three pivotal trials showed PRADAXA as non-inferior to warfarin in reduction of DVT and PE recurrence; fourth pivotal trial showed PRADAXA reduced risk of recurrence by 92 percent compared to placebo RIDGEFIELD, Conn., April 7, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa(®) (dabigatran etexilate mesylate) for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in...

2014-04-02 23:33:40

Boehringer Ingelheim ordered to pay nearly $1 million fine for obstructing pre-trial evidence gathering. National network of attorneys continues policy of no-cost consultations to consumers inquiring about legal options to seek compensation over these allegations. San Diego, CA (PRWEB) April 02, 2014 http://www.resource4thepeople.com/defectivedrugs/pradaxa-lawsuits.html Resource4thePeople today announced important new developments involving lawsuits* alleging that the popular...

2014-04-02 16:23:15

DUBLIN, Apr. 02, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/gd4n67/global_and ) has announced the addition of the "Global and Chinese Feed Chlortetracycline Industry Report 2014" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) The Global and Chinese Feed Chlortetracycline Industry Report 2014 is a professional and in-depth study on the current state of the global feed chlortetracycline industry with a focus on...

2014-03-29 23:01:26

The Firm is investigating Byetta lawsuits on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis or thyroid cancer due to their use of Byetta. New York, New York (PRWEB) March 29, 2014 As Byetta lawsuits (http://www.byettalawsuit.com) continue to move forward in federal court, Bernstein Liebhard LLP notes that a newly published study is raising questions about the costs and benefits associated with newer medications used in the treatment of Type 2 diabetes....

2014-03-28 23:25:44

The DrugRisk Center is the largest source on the Web for information on prescription drug research, side effects and legal news. Visit http://www.DrugRisk.com Chicago, IL (PRWEB) March 28, 2014 The prescription drug safety center DrugRisk.com is announcing updated legal news on the site for patients taking the blood thinner Pradaxa. Recent court documents show a federal court has scheduled the first lawsuit alleging the drug caused internal bleeding injury or death to start in...

2014-03-28 08:27:23

Cardiologists also believe their patients' top concern is the fear of experiencing a clot that leads to a stroke; real-world challenges may influence treatment decisions RIDGEFIELD, Conn., March 28, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced results from a new survey of cardiologists to understand their perceptions about anticoagulation, stroke risk reduction and goals for non-valvular atrial fibrillation (NVAF) therapy when prescribing warfarin or...

2014-03-24 08:28:21

Presentations to include research around antidote for dabigatran, a post-hoc analysis of data from the RE-LY® trial and data from the GLORIA(TM)-AF registry RIDGEFIELD, Conn., March 24, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that data from three company-sponsored PRADAXA studies will be presented at the American College of Cardiology 63(rd) Annual Scientific Session (ACC.14) in Washington, D.C., March 29 to 31, 2014. An oral presentation will...

2014-03-24 08:26:49

Results Show Highest Rate of Control Ever Observed with Warfarin in Real-world Setting, Surpassing Thresholds for Cost-Effectiveness of Newer Agents Identified in Five Recent Independent Studies WALTHAM, Mass., March 24, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR) today announced the publication of the largest-ever study of warfarin patient self-testing, which demonstrated that weekly International Normalized Ratio (INR) testing significantly improves control of warfarin, as measured...

2014-03-23 23:01:59

Federal Judge Overseeing More than 2,300 Pradaxa Lawsuits Schedules Four Bellwether Trials, First of Which Will Begin in September 2014. Columbus, OH (PRWEB) March 23, 2014 The federal judge overseeing thousands of Pradaxa lawsuits in the U.S. District Court, Southern District of Illinois, has established new dates for the litigation’s first bellwether trials, Wright & Schulte LLC reports. According to a Pretrial Order issued on March 5, 2014, by U.S. District Judge David Herndon,...

2014-03-19 23:29:43

http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news. Visit the DrugNews Center today. New York, NY (PRWEB) March 19, 2014 The prescription drug safety advocates at DrugNews.net are alerting patients taking the blood thinner Pradaxa of new information on the site. Updated court records show the number of lawsuits alleging the drug caused internal bleeding have risen from February to March*. DrugNews is a free resource...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related